DE69328065D1 - Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen - Google Patents

Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen

Info

Publication number
DE69328065D1
DE69328065D1 DE69328065T DE69328065T DE69328065D1 DE 69328065 D1 DE69328065 D1 DE 69328065D1 DE 69328065 T DE69328065 T DE 69328065T DE 69328065 T DE69328065 T DE 69328065T DE 69328065 D1 DE69328065 D1 DE 69328065D1
Authority
DE
Germany
Prior art keywords
fibronectin
weight
treat epithelial
ointment used
epithelial injuries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328065T
Other languages
English (en)
Other versions
DE69328065T2 (de
Inventor
Per Alm
Pia Alm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procell Bioteknik i Hornefors AB
Original Assignee
Procell Bioteknik i Hornefors AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procell Bioteknik i Hornefors AB filed Critical Procell Bioteknik i Hornefors AB
Publication of DE69328065D1 publication Critical patent/DE69328065D1/de
Application granted granted Critical
Publication of DE69328065T2 publication Critical patent/DE69328065T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69328065T 1992-10-05 1993-09-21 Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen Expired - Lifetime DE69328065T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202895A SE470477B (sv) 1992-10-05 1992-10-05 Salva innehållande fibronektin för behandling av sår

Publications (2)

Publication Number Publication Date
DE69328065D1 true DE69328065D1 (de) 2000-04-20
DE69328065T2 DE69328065T2 (de) 2000-11-02

Family

ID=20387373

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328065T Expired - Lifetime DE69328065T2 (de) 1992-10-05 1993-09-21 Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen

Country Status (9)

Country Link
US (1) US5733870A (de)
EP (1) EP0592380B1 (de)
JP (1) JP3715659B2 (de)
AT (1) ATE190500T1 (de)
AU (1) AU4880193A (de)
CA (1) CA2107598A1 (de)
DE (1) DE69328065T2 (de)
ES (1) ES2146223T3 (de)
SE (1) SE470477B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
GB9705340D0 (en) * 1997-03-14 1997-04-30 Nycomed Imaging As Compositions
FR2777461B1 (fr) * 1998-04-16 2003-04-25 Ceetal Sa Lab Agent de soin du trayon et procede de preparation
US6917095B1 (en) 2000-05-30 2005-07-12 Altera Corporation Integrated radio frequency circuits
JP4313033B2 (ja) * 2002-12-27 2009-08-12 株式会社日本点眼薬研究所 眼科用治療組成物
WO2004089357A2 (en) * 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
JPS5976007A (ja) * 1982-10-22 1984-04-28 Shiseido Co Ltd 化粧料
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
US5053388A (en) * 1987-11-09 1991-10-01 Chiron Ophthalmics, Inc. Wound healing composition and method
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
JP3088744B2 (ja) * 1990-05-28 2000-09-18 日本ケミカルリサーチ株式会社 フィブロネクチン組成物

Also Published As

Publication number Publication date
JPH06199684A (ja) 1994-07-19
US5733870A (en) 1998-03-31
SE9202895D0 (sv) 1992-10-05
EP0592380A1 (de) 1994-04-13
SE9202895L (sv) 1994-04-06
DE69328065T2 (de) 2000-11-02
AU4880193A (en) 1994-04-21
ATE190500T1 (de) 2000-04-15
CA2107598A1 (en) 1994-04-06
JP3715659B2 (ja) 2005-11-09
EP0592380B1 (de) 2000-03-15
SE470477B (sv) 1994-05-24
ES2146223T3 (es) 2000-08-01

Similar Documents

Publication Publication Date Title
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
IT1111792B (it) Zolle di coltura particolarmente per l'utilizzazione in vivai
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
ATE84216T1 (de) Topische salbe.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
FR2562382B1 (fr) Dispositif permettant l'enlevement des baches, films ou filets mis en place pour certaines cultures
DE69328065D1 (de) Fibronektin enthaltende Salbe zur Behandlung von epithelialen Verletzungen
ATE131154T1 (de) Phenylalkan(en)säuren.
KR920005691A (ko) 인터루킨-1 매개병의 치료방법
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
ES480532A1 (es) Un metodo para preparar 4-aril-5-tiazol-carboxilatos susti- tuidos en la posicion 2.
ATE118350T1 (de) Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
ES2110602T3 (es) Nuevos derivados de 2,3-dihidro-2,2,4,6,7-pentaalquil-5-benzofuranoles.
FR2674101B1 (fr) Procede pour eviter les alterations chimiques de legumes, fruits ou fleurs provoquees par le bromure de methyle et agent utilisable dans ce procede.
FR2620439B1 (fr) Procede et dispositif de traitement par fermentation methanique d'eaux residuaires lipidiques
FR2656528B1 (fr) Formule combinee de cimetidine-pirenzepine pour le traitement des ulceres simples de l'estomac et des erosions et procede de traitement.
DE59310343D1 (de) Desinfektionsmittel
NO930377L (no) Fremgangsmaate for behandling av ferskt kjoett for forbedring av dettes holdbarhet
FR2687929B1 (fr) Procede d'epuration d'excrements animaliers et son dispositif.
FR2686814B1 (fr) Procede de traitement et de valorisation des dejections animales obtenues en elevage industriel hors-sol, telles que le lisier.
DE69227899D1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition